CIK 0000072444
- Accelerated filer
- Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 591212264
- Phone
- +1 650-550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- 4 Open-market sale Director sold 6,600,000 shares at an average $3.05 ($20,122,351)
- 4 Open-market sale Director sold 60,000 shares at $3.28 ($196,500)
- 3/A Insider 3/A
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 200,000 shares at an average $0.34 ($67,256)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 20,000 shares at $0.38 ($7,680)
- 4 Open-market buy 10% owner bought 564,000 shares at an average $0.36 ($203,200)
- 4 Open-market buy 10% owner bought 436,000 shares at an average $0.35 ($150,552)
- 4 Open-market buy 10% owner bought 7,333,333 shares at an average $0.29 ($2,143,078)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy President and Chief Executive bought 166,667 shares at $0.30 ($50,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 9 of 28 · 550 filings